The global Mycoplasma Testing Market was valued at USD 941.56 million in 2023 and is projected to reach USD 2,943.09 million by 2032, expanding at
Allied Market Research published a report, titled, “Mycoplasma Testing Market By Product (Instruments, Kits & Reagents, and Services), By Technology (PCR, ELISA, Microbial Culture Techniques, and Enzymatic
The Mycoplasma Testing Market has emerged as a vital component in the pharmaceutical and biotechnology sectors, reflecting growing concerns over contamination in cell cultures and
The mycoplasma testing market plays a crucial role in ensuring the safety, purity, and reliability of biopharmaceutical products, cell-based research, and vaccine development. Mycoplasma contamination